Vertex Pharmaceuticals Inc. (VRTX) News Headlines

▮ More

Date

Headline

10/19/2021 8:06:57 AM Vertex To Present Long-Term Data Demonstrating Significant Benefits Of Treatment With CFTR Modulators

10/18/2021 8:02:42 AM Vertex Announces Positive Data In Phase 1/2 Trial Dosed With VX-880 For Type 1 Diabetes Treatment

10/18/2021 7:34:49 AM Vertex Announces Positive Day 90 Data In Phase 1/2 Trial Of VX-880 For Type 1 Diabetes

9/15/2021 10:03:19 AM Vertex To Present At The Morgan Stanley Virtual Global Healthcare Conference; Webcast At 11:00 AM ET

8/26/2021 7:05:58 AM Vertex Publishes Phase 3 Results For TRIKAFTA In Cystic Fibrosis In The New England Journal Of Medicine

8/4/2021 8:34:16 AM Vertex Appoints Stuart Arbuckle As COO

7/29/2021 6:02:08 PM Vertex Pharmaceuticals Lifts FY21 Revenue Outlook

7/29/2021 4:16:51 PM Vertex Pharma Q2 EPS $0.26 Vs. $3.18 Year Ago

7/29/2021 4:14:14 PM Vertex Pharmaceuticals Inc. (VRTX) Has Raised Its 2021 Revenue Estimate To $7.2 - $7.4 Bln From $6.7 - $6.9 Bln

7/29/2021 4:11:32 PM Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates

7/29/2021 2:30:03 PM Vertex Pharmaceuticals Q2 21 Earnings Conference Call At 5:30 PM ET

7/28/2021 8:48:25 AM Vertex To Initiate Phase 3 Program For Once-Daily Triple Combination Regimen In Cystic Fibrosis

7/28/2021 8:05:17 AM Vertex To Initiate Phase 3 Development Program For Once-Daily Triple Combination Regimen In People With Cystic Fibrosis

6/28/2021 9:31:43 AM Vertex Announces National Reimbursement Deal In France For KAFTRIO And SYMKEVI For Eligible Cystic Fibrosis Patients

6/11/2021 10:02:59 AM Stock Alert: Vertex Pharmaceuticals Down On Dropping Plans To Advance VX-864 Study Into Late Stage

6/11/2021 3:11:59 AM Vertex, CRISPR Announce New Data On 22 Patients Treated With Investigational CRISPR/Cas9-based Gene-editing Therapy

6/9/2021 8:41:50 AM FDA Approves Expanded Use Of Vertex Pharma's Cystic Fibrosis Drug In Younger Patients

6/9/2021 8:37:13 AM FDA Oks Vertex's Trikafta In Children With CF Ages 6 Through 11 With Certain Mutations

4/29/2021 4:47:43 PM Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

4/29/2021 4:13:30 PM Vertex Pharma Q1 EPS $2.49 Vs. $2.29 Year Ago